FDA approves new drug to treat a form of Gaucher disease

The U.S. Food and Drug Administration today approved Cerdelga (eliglustat) for the long-term treatment of adult patients with the Type 1 form of Gaucher disease, a rare genetic disorder.

Source: Food and Drug Administration - August 19, 2014 Category: American Health Source Type: news